Drug – bio-affecting and body treating compositions – Immunoglobulin – antiserum – antibody – or antibody fragment,... – Monoclonal antibody or fragment thereof
Patent
1994-10-25
1998-03-24
Sidberry, Hazel F.
Drug, bio-affecting and body treating compositions
Immunoglobulin, antiserum, antibody, or antibody fragment,...
Monoclonal antibody or fragment thereof
4241411, 4241431, 4241521, 5303881, 53038875, 5303895, 514 2, C07K 1600, C07K 1618, A61K 37395, C12P 2108
Patent
active
057309809
ABSTRACT:
The present invention concerns a method of treating CD14-mediated host inflammatory response to LPS often associated with sepsis comprising administering a therapeutically effective amount of anti-CD14 antibody molecules. A therapeutic composition comprising anti-CD14 antibody molecules in a pharmaceutically acceptable excipient is also contemplated.
REFERENCES:
patent: 4834976 (1989-05-01), Rosol et al.
patent: 4918163 (1990-04-01), Young et al.
patent: 5057598 (1991-10-01), Pollack et al.
Bogman, et al., "Diagnosis of Renal Allograft Rejection by Macrophage Immunostaining with a CD14 Monoclonal Antibody, WT14", The Lancet, 235-238, 1989.
Hinshaw et al Surg, Gynecol. & Obstetrics 145:1-1, 1977 Responses of the Baboon to live E. coli organisms & Endotoxin.
Hesse et al Surg., Gynecol & Obstet 166:147-153 1988 Cytokine appearance in Human Endotokemic & Rumate Bacteremia.
Spalding Bio/Technology Apr. 1993 "In Shocking Syngergies, Sepsis tallies third victim" pp. 428-429.
Gibbs, Scientific American, Jul. 1993, Try, Try Again making antibodies more useful by making them more human, pp. 101-103.
Cross et al, Inf & Immun 61:2741-2747 1993 Choice of Bacteria in Animal Models of Sepsis.
Washington Post Jan. 18, 1993 Centocor Stops Trials of Flagship Drug.
Ashman et al. Blood 69:886-892 1987.
Van Voorhis et al J. App. Med 158:126-145 1983.
Greisman et al-Experimental Gram-neg. Bacterial Sepsis : Prevention of Mortality Not Preventable by Antibiotics alone.
Tracey et al Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia.
Ashmun, et al., Blood, 69:886-892 (1987).
Bazil, et al., Eur. J. Immunol., 16:1583-1589 (1986).
Beutler et al., Science, 229:869 (1985).
Beutler, et al., N. Eng. J. Med., 316:379 (1987).
Ehlenberger, et al., J. Exp. Med., 145:357-371 (1977).
Espevik, et al., J. Immunol. Meth., 95:99-105 (1986).
Ferrero, et al., Nucleic Acids Research, vol. 16:4173 (1988).
Goyert, et al., Science, 239:497-500 (1988).
Mathison, et al., J. Clin. Invest., 81:1925 (1988).
Michie, et al., New Eng. J. Med., 318:1481-1486 (1988).
Tobias, et al., J. Exp. Med., 164:777-793 (1986).
Tobias, et al., J. Biol. Chem., 263:13479-13481 (1988).
Tobias, et al., J. Biol. Chem., 264:1087-10871 (1989).
Tracey, et al., Nature, 330:662-664 (1987).
van Deventer, et al., Lancet, 1:605-608 (1988).
Van Voorhis, et al., J. Exp. Med., 158:126-145 (1983).
Waage, et al., Lancet, 1:355-357 (1987).
Wright, et al., J. Exp. Med., 156:1149-1164 (1982).
Wright, et al., J. Exp. Med., 158:1338-1343.
Wright, et al., Proc. Natl. Acad. Sci. USA, 80:5699-5703 (1983).
Wright, et al., J. Exp. Med., 164:1876-1888 (1986).
Scnett et al Immunol. Lett 19:321-328, 1988.
Oden et al Develop Biol Standard 24:181-187, 1974.
Hinshaw et al, Surg Gynecol & Obstetrics 148:1-11, 1977.
Hess et al Surg Gynecol & Obstet. 166:147-153 1988.
Cross et al Inf & Immun 61:2741-2747 1993.
Fink et al Journal of Surg. Res. 49:186-196 1990 Current Research Res: Laboratory Models of Sepsis & Septic Shock.
Sperjers et al Vaccine 7:364-368, 1989.
Cross et al Journal & Endotoxin Research pp. 57-69, 1994.
Mathison John C.
Tobias Peter
Ulevitch Richard
Wright Samuel D.
Sidberry Hazel F.
The Scripps Research Institute
LandOfFree
Methods and compositions for ameliorating the symptoms of sepsis does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for ameliorating the symptoms of sepsis, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for ameliorating the symptoms of sepsis will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2286712